Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarepta Therapeutics
Biotech
Sarepta CEO to step down as DM1 hits home—Chutes & Ladders
Sarepta CEO to step down as DM1 hits close to home. Pops descends from Alkermes CEO seat. Former Novartis CMO Tsai saunters to Daiichi.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Feb 27, 2026 8:30am
Fierce Pharma
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
Fierce Biotech's Rotten Tomatoes of 2025
Dec 16, 2025 4:30am
Dyne readies FDA push after DMD exon 51 med excels in trial
Dec 8, 2025 10:50am
Sarepta shares safety update on DM1 RNA med
Nov 24, 2025 4:00pm
Fierce Pharma
Sarepta, despite key trial flop, will seek full nod for DMD meds
Nov 4, 2025 7:56am